Brukinsa Европейский союз - словенский - EMA (European Medicines Agency)

brukinsa

beigene ireland ltd - zanubrutinib - waldenstrom macroglobulinemia - antineoplastična sredstva - brukinsa as monotherapy is indicated for the treatment of adult patients with waldenström’s macroglobulinaemia (wm) who have received at least one prior therapy, or in first line treatment for patients unsuitable for chemo-immunotherapy. brukinsa as monotherapy is indicated for the treatment of adult patients with marginal zone lymphoma (mzl) who have received at least one prior anti-cd20-based therapy. brukinsa as monotherapy is indicated for the treatment of adult patients with chronic lymphocytic leukemia (cll).

TEGRETOL 200 mg tablete Словения - словенский - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

tegretol 200 mg tablete

novartis pharma gmbh - karbamazepin - tableta - karbamazepin 200 mg / 1 tableta - karbamazepin

TEGRETOL CR 400 mg tablete s podaljšanim sproščanjem Словения - словенский - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

tegretol cr 400 mg tablete s podaljšanim sproščanjem

novartis pharma gmbh - karbamazepin - tableta s podaljšanim sproščanjem - karbamazepin 400 mg / 1 tableta - karbamazepin

Jaypirca Европейский союз - словенский - EMA (European Medicines Agency)

jaypirca

eli lilly nederland b.v. - pirtobrutinib - limfom, mantle cell - proteinska kinaza inhibitorji - treatment of mantle cell lymphoma (mcl).